Becoming a global leader in biosimilars development
Leadership Team
Our Promoters
P.V. Ram Prasad Reddy
Non-Executive Director
K. Nityananda Reddy
Vice Chairman & Managing Director
Latest News
Press Release
19 September 25
CuraTeQ Biologics announces positive Phase 3 study results for Denosumab biosimilar
Read More
Press Release
04 July 25
CuraTeQ Biologics receives EC marketing authorization for Dazublys – Trastuzumab biosimilar
Read More
Press Release
26 April 25
CuraTeQ Biologics receives CHMP positive opinion for Dazublys – Trastuzumab biosimilar
Read More
Press Release
10 April 25
CuraTeQ Biologics successfully completes Phase I study for Denosumab biosimilar
Read More
Press Release
31 January 25
CuraTeQ Biologics receives CHMP positive opinion for Pegfilgrastim biosimilar
Read More
Press Release
21 December 24
CuraTeQ Biologics receives UK MHRA approval for Bevqolva™ (Bevacizumab biosimilar)
Read More
Press Release
13 December 24
CuraTeQ Biologics receives CHMP positive opinion for Filgrastim biosimilar
Read More
Press Release
12 November 24
EMA grants GMP certificate to CuraTeQ Biologics’ manufacturing facility in Hyderabad
Read More
Press Release
15 March 24